Author

Lu Qian

Fred Hutch Cancer CenterPrimary ORCID profile (0000-0001-6922-1125 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Lu QianiD1 paper · Southern Marine Science and Engineering Guangdong Laboratory (Zhuhai)

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anirban MaitraiD· 1 shared Anna E LokshiniD· 1 shared Ben StaaliD· 1 shared Brian B. HaabiD· 1 shared Camden LopeziD· 1 shared Christine Worthington· 1 shared Denise Prosser· 1 shared Gopalakrishnan Natarajan· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anirban MaitraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Rigorous Multi-Laboratory Study of Known PDAC Biomarkers Identifies Increased Sensitivity and Specificity Over CA19-9 Alone

Brian B. Haab, Lu Qian, Ben Staal, Maneesh Jain, Johannes Francois Fahrmann, Christine Worthington, Denise Prosser, Liudmila Velokokhatnaya, Camden Lopez, Runlong Tang, Mark W. Hurd, Gopalakrishnan Natarajan, Sushil Kumar K, Lynette M. Smith, Samir Hanash, , Randall E. Brand

This study evaluates combinations of PDAC biomarkers across multiple labs, finding improved sensitivity and specificity for early-stage detection compared to CA19-9 alone.

Cancer Letters · Sep 12, 2024Peer-reviewedCancer Biology